Compare HWKN & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HWKN | BLLN |
|---|---|---|
| Founded | 1938 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.9B |
| IPO Year | N/A | 2025 |
| Metric | HWKN | BLLN |
|---|---|---|
| Price | $152.99 | $87.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $200.00 | $137.83 |
| AVG Volume (30 Days) | 159.3K | ★ 259.9K |
| Earning Date | 01-28-2026 | 12-09-2025 |
| Dividend Yield | ★ 0.50% | N/A |
| EPS Growth | ★ 1.59 | N/A |
| EPS | ★ 3.97 | N/A |
| Revenue | ★ $1,045,229,000.00 | $254,136,000.00 |
| Revenue This Year | $14.22 | $98.01 |
| Revenue Next Year | $7.46 | $35.84 |
| P/E Ratio | $38.30 | ★ N/A |
| Revenue Growth | 11.86 | ★ 254.30 |
| 52 Week Low | $98.30 | $80.51 |
| 52 Week High | $186.15 | $138.70 |
| Indicator | HWKN | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 56.88 | N/A |
| Support Level | $144.95 | N/A |
| Resistance Level | $156.17 | N/A |
| Average True Range (ATR) | 5.38 | 0.00 |
| MACD | 0.12 | 0.00 |
| Stochastic Oscillator | 55.97 | 0.00 |
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.